WO2017030388A1 - Composition for treating skin wounds - Google Patents

Composition for treating skin wounds Download PDF

Info

Publication number
WO2017030388A1
WO2017030388A1 PCT/KR2016/009107 KR2016009107W WO2017030388A1 WO 2017030388 A1 WO2017030388 A1 WO 2017030388A1 KR 2016009107 W KR2016009107 W KR 2016009107W WO 2017030388 A1 WO2017030388 A1 WO 2017030388A1
Authority
WO
WIPO (PCT)
Prior art keywords
wound
skin
collagen
glycerin
present
Prior art date
Application number
PCT/KR2016/009107
Other languages
French (fr)
Korean (ko)
Other versions
WO2017030388A9 (en
Inventor
이상철
Original Assignee
이상철
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이상철 filed Critical 이상철
Priority to CN201680019591.4A priority Critical patent/CN107427561A/en
Publication of WO2017030388A1 publication Critical patent/WO2017030388A1/en
Publication of WO2017030388A9 publication Critical patent/WO2017030388A9/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Definitions

  • the present invention relates to a composition for treating skin wounds, and more particularly, to a composition for treating skin wounds, which can alleviate and heal pain in skin wounds such as burns, traumas, wounds and pressure sores.
  • Skin is an important organ with the largest surface area in the body, and if the skin is extensively damaged, it may lose its life due to dehydration.
  • the skin must be resistant to physical irritation and elasticity because it serves to protect against and to prevent dehydration and to regulate body temperature by inhibiting evaporation of the human body.
  • the wound is inevitable skin transplantation in the case of wounds that are not primary suture Since the scars are left behind, it is necessary to promptly treat the wound in order to repair the damaged skin tissue, and it is essential to dress and treat the secondary to minimize various side effects.
  • the damaged skin or mucous membrane contains dying cells, microorganisms, contaminants, Cells, microorganisms and contaminants contained must be removed or degraded, whereby protease is secreted to degrade the cells, microorganisms and contaminants.
  • MMPs matrix metalloproteins
  • intercellular matrix MMPs: matrix metalloproteins
  • MMPs matrix metalloproteins
  • proteins proteins, collagen, elastin hyaluronic acid, and the like, which fill a space between cells.
  • intercellular matrices are of different types, they require different types of neutralizing specific polyphenols. These are two specific plant extracts that are not related to each other, thereby stopping the breakdown of the intercellular matrix and having a synergistic effect on cell growth. Thus, different types of intercellular matrix (MMPs) can be converted into two neutralizing polyphenols or polysaccharides. Alternatively, it is possible to have three types.
  • the vegetable extract (herb extract) uses tannic acid, which has been used for all leather since Egyptian times, because tannic acid has the ability to bind proteins.
  • the tannic acid is a component in the persimmon persimmon, and in terms of molecular structure, polyphenols and polysaccharides are attached, and procyanidine or ansocyanidin in a dark-colored fruit with antioxidant activity. Also called (anthocyanidine).
  • Herbal extracts that have the ability to bind to proteolytic enzymes are a type of Alchemilla vulgaris, and other extracts bind to viruses or other proteins. Therefore, if glycerin contains other herbal extracts, it is effective for other types of wounds.
  • the plant extract may neutralize proteolytic enzymes by combining polyphenols and polysaccharides known to precipitate large molecules with proteolytic enzymes.
  • the polyphenols and polysaccharides have a strong affinity for proteins, and some polyphenols or polysaccharides bind to bacteria or viral proteins to reduce the release of toxic substances of infection, microbial origin, and cell growth. It helps to promote.
  • Alchemilla Vulgaris is a herb that has been used for the treatment of gastrointestinal disorders and wounds since the Middle Ages, and Mimosa (Timosa Tenuiflora) has traditionally been used to treat skin wounds, burns, and oral wounds. Both herbal extracts are rich in Procyanidins.
  • procyanidins promote wound healing
  • MMPs cellular degrading enzymes
  • Collagen is also used for wound healing, which is a fibrous protein found in most connective tissues such as skin, muscles and tendons, especially in animals and humans. When collagen comes into contact with blood, platelets aggregate to collagen and maintain coagulation factors that are released together with plasma to finally form fibrin and thrombus to act as a hemostatic action.
  • the first formulation is a powder.
  • Collagen is the first protein to be temporarily formed in the empty space during the wound treatment process, and despite the expectation that it will promote wound healing, the powder formulation has been limited in use due to some disadvantages.
  • Sponge-type collagen products have been developed to compensate for these drawbacks, but this formulation also caused other drawbacks.
  • the sponge-like product was covered on the wound area, the wound treatment did not have much effect to promote the wound treatment because it could not be in close contact with the wound and an empty space was created.
  • This product was prepared by mixing saline with collagen powder, paste or paste, and applying it closely to the wound surface to easily remove it from the wound after hemostasis and hemostasis.
  • the prior art is not only used as a hemostatic agent by mixing saline with collagen to be in close contact with the wound surface, but there is an insufficient problem of promoting wound healing, and moisture is easily evaporated. There is a problem that the pain relief effect is low and dries easily.
  • An object of the present invention to solve the above problems is to discharge the exudate from the inside of the wound, to remove microorganisms and other contaminants, to inhibit proteolytic enzymes to neutralize their activity by inhibiting the decomposition of the matrix cell growth of the wound site And not only to promote treatment, but also to increase the density by adding collagen to increase the blocking effect with the air to increase the pain relief effect.
  • Means of the present invention according to the solution of the above problem is characterized by mixing 5wt% to 50wt% of powdered collagen in a liquid glycerin containing 2wt% to 5wt% of the vegetable extract to 50wt% to 95wt%.
  • the vegetable extract is Vitis vinifera, Camellia sinensis, Basinium sp., Vaccinium sp., Vaccinoum myrtillus, Alchemilla vulgaris (Alchemilla vulgaris), Mimosa tenuiflora (Mimosa tenuiflora), Echinacea purpura (Echinacea purpura) is characterized in that the extract.
  • the effect of the present invention according to the problem solution means by applying collagen to the skin wound by mixing the glycerin containing the herbal extract, the glycerin applied to the skin wound is discharged exudates from the inside of the skin wound by the high osmotic pressure to the skin wound Sterilizes infected bacteria and other contaminants, herbal extracts promote wound healing by neutralizing proteolytic enzymes that break down the intercellular matrix, repairing the matrix and promoting cell growth, and the collagen accelerates protease faster It not only neutralizes, but also maintains a moisturizing condition by inhibiting water evaporation along with glycerin, which acts as a pain relief and wound cover and promotes wound healing.
  • the present invention is prepared by mixing powdered collagen (collagen) to a liquid glycerin (Glycerol).
  • the glycerin (Glycerol) will contain any one of vegetable extracts or herbal extracts. Preferably it contains a herb extract.
  • the glycerin (Glycerol) can heal the wound with a high moisturizing effect, but only a very small effect of relieving pain by the moisturizing effect.
  • the high concentration of glycerin constricts the cells in the sieve and draws out exudate that moves out of the tissue, and the exudate exudes in combination with the herb extract, which will be described later, to prevent it from entering the sieve.
  • the osmotic pressure is high so that the exudate in the skin moves toward the glycerin, and the herbal extracts in the hypertonic solution do not re-enter the tissue by catching different substances. Therefore, the glycerin is combined with the herbal extract to apply a film on the wound in a state where the viscosity is higher.
  • the glycerin has a high osmotic pressure and a binding force in the form of a polymer, so it exists outside the wound without penetrating into the tissue. Therefore, exudates come out of the tissues along with viruses and contaminants in the wound to clean the wound and facilitate the healing of the wound.
  • the herbal extract is a tannin component present in the plant, and the hydroxyl group and the carbonic acid group of the glycerin are combined to form a precipitate, and each tannin has a different kind of action. Therefore, different types of herbal extracts have different effects, and there are various types of diseases that can be treated.
  • the collagen is a triple helical structure, especially a protein substance with a high hydroproline content, and is insoluble in water, dilute acid and dilute alkali, but dissolves and becomes gelatin. When applied to the wound, it acts as a temporary skin to promote wound healing.
  • liquid glycerin 50wt% to 95wt% of liquid glycerin is mixed with 5wt% to 50wt% of collagen in powder form of 40 to 60 mesh particles, and then prepared by lowering the internal air pressure.
  • the liquid glycerin will contain a vegetable extract.
  • the vegetable extract will contain 2wt% ⁇ 5wt%.
  • the plant extracts are Vitis vinifera, Camellia sinensis, Vaccinium sp., Vaccinoum myrtillus, Alchemilla vulgaris ), Extracts of any one of Mimosa tenuiflora and Echinacea purpura will be used.
  • the present invention preferably contains 90 wt% of the liquid glycerin and 10 wt% of the collagen.
  • the active hypertonic component releases the exudates from the inside of the wound to the outside by glycerin, thereby separating and discharging the microorganisms and other contaminants of the wound outwards, thereby facilitating the healing of the wound.
  • the exudates of microorganisms and contaminants that are separated and discharged to the outside are adsorbed with procyanidin-rich herbal extracts to prevent the exudates from entering the inside again and neutralize their activities by inhibiting proteolytic enzymes that destroy the matrix between cells. Proliferation of the matrix between cells promotes treatment.
  • the collagen is a structural protein constituting the extracellular matrix, a white transparent unbranched fibrils composed of a plurality of sugar protein molecules.
  • the monomer of collagen protein is procollagen, and the procollagen molecule is composed of three long and thin spiral chains.
  • the electron microscope has a stable triple helix space structure of 1.5nm in diameter, 300nm in length and 2.85 ⁇ 105 in relative molecular mass. It is composed of special amino acids.
  • the collagen is a protein that connects cells to cells to form flesh and connective tissue, and exists as an intercellular matrix, and accounts for 25% to 35% of the proteins constituting the body and is a fibrous form of tendons, ligaments, It is present in fibrous tissues such as skin.
  • the collagen is a special protein contained in animal skin or cartilage. It is insoluble in water, extracted by heating in water, and extracted by heating.
  • the steric structure is collapsed to have a denatured protein called gelatin, that is, a liquid upon heating and a solid upon cooling.
  • the collagen when applied to the wound of the skin, it combines the cells of the skin and the cells to promote the thickness of the skin, and also inhibits the evaporation of the moisture of the skin to have a hemostatic action, resistance, disintegration and biocompatibility, clinical hemostasis And promote cell growth to promote wound healing.
  • Example 1 Example 2 Example 3 Glycerin (wt%) + Herb Extract (wt%) 50 90 95 Collagen (wt%) 50 10 5
  • the present invention in the form of a gel prepared in Examples 1 to 3 was treated by applying a thickness of 1 g to the wound of a bed sore patient.
  • the wound area that started treatment with the general treatment showed a deteriorated state even after 10 days once a day, but after 7 weeks of treatment three times a week with the present invention, the wound remains. Neatly healed.
  • the present invention was treated by applying a 1g thickness to the wound of the bed sore patient, as shown in the photo of FIG.
  • the wound site that started treatment with the general treatment showed a worse condition after 11 weeks once a day, but after 4 treatments with the present invention 4 times a week, scars remained relatively little at the wound site. Neatly healed.
  • the present invention was treated by applying a thickness of 1g to the wound of the bed sore patient, as shown in the photo of FIG.
  • the decubitus area that started treatment with a general treatment showed a lot of wounds after 1 week once a week, but as a result of treatment twice a week and 10 times every 5 weeks with the present invention, the wound site was neat. It did not heal, but it was almost healing.
  • the present invention was also treated by applying a thickness of 1 g to the wound of the burn patient, as shown in the photograph of FIG. 4.
  • the burned area that started treatment with the general treatment showed a lot of wounds after 12 weeks once a day, but the treatment with the general treatment was performed twice a week and 10 times in 5 weeks with the present invention.
  • the burn wound was almost neatly healed, it was found that in the case of the burn wound that started treatment with the present invention, the wound wound was healed in a relatively fast time compared to the number of times of the start of treatment with the general treatment.
  • the wounds of the bedsores and burns with the present invention are cured in a considerably faster time than the general treatment, and the wounds are cleanly cleared with almost no scars on the wounds. I could see that.
  • the prior art is not only used as a hemostatic agent by adhering saline to collagen but in close contact with the wound surface, and there is an insufficient problem of promoting wound healing.
  • the present invention there was a problem that the relaxation effect was low and easily dried, so that the conventional problem could be solved.

Abstract

The present invention relates to a composition for treating skin wounds. In the present invention, a herb extract-containing glycerin is mixed with a collagen and applied to a skin wound. The glycerin applied to the skin wound kills the infecting bacteria and other contaminants by using high osmotic pressure to discharge an exudate from inside the skin to the skin wound. The herb extract stimulates wound treatment by neutralizing intercellular matrix-destroying proteolytic enzymes to regenerate the matrix and thereby stimulate cell growth. The added collagen not only neutralizes collagenases more quickly, but by combining with the glycerin to suppress the evaporation of moisture and thereby maintain the moisturized state, exhibits a pain-relieving effect, covers the wound, and stimulates the wound treatment effect.

Description

피부 상처 치료조성물Skin Wound Healing Composition
본 발명은 피부 상처 치료조성물에 관한 것으로, 상세하게는 화상, 외상, 창상, 욕창 등의 피부 상처부위에 통증을 완화하고 치유할 수 있도록 한 피부 상처 치료조성물에 관한 것이다.The present invention relates to a composition for treating skin wounds, and more particularly, to a composition for treating skin wounds, which can alleviate and heal pain in skin wounds such as burns, traumas, wounds and pressure sores.
피부는 신체에서 가장 큰 표면적을 차지하는 중요한 기관으로, 상기 피부가 광범위하게 손상될 경우 탈수로 인해 생명을 잃을 수도 있으며, 또한 상기 피부는 외부의 미생물이나 자외선, 세균, 화학물질과 같은 여러 가지 유해 환경으로부터 보호하는 역할 및 인체의 수분증발을 억제함으로써 탈수를 방지하고 체온을 조절하는 역할을 하기 때문에, 피부는 물리적 자극에 강해야 하고 탄력성이 있다.Skin is an important organ with the largest surface area in the body, and if the skin is extensively damaged, it may lose its life due to dehydration. The skin must be resistant to physical irritation and elasticity because it serves to protect against and to prevent dehydration and to regulate body temperature by inhibiting evaporation of the human body.
그러나, 상기 자극에 강하고 탄성력을 가진 피부가 화상, 외상, 창상, 욕창 및 피부질환 등과 같은 다양한 원인에 의해 손상이 일어나는 경우, 이때 상기 손상된 피부가 1차 봉합이 불가능한 창상의 경우, 피부이식이 불가피한 심한 흉터를 남기게 되므로 손상된 피부조직을 복구하기 위하여 상처의 치료를 신속히 하여야 함은 물론, 2차적으로 각종 부작용을 최소화하기 위해 드레싱하여 치료하는 것이 필수적이다.However, if the skin is resistant to elasticity and elasticity is caused by various causes such as burns, trauma, wounds, bedsores and skin diseases, the wound is inevitable skin transplantation in the case of wounds that are not primary suture Since the scars are left behind, it is necessary to promptly treat the wound in order to repair the damaged skin tissue, and it is essential to dress and treat the secondary to minimize various side effects.
또한 상기 피부의 상처가 신체의 주요 부분을 덮고 있는 피부나 점막의 손상과 함께 내부조직까지 손상된 경우, 상기 손상된 피부나 점막에는 죽어가는 세포, 미생물, 오염물질이 포함되어 있어, 상기 피부나 점막에 포함된 세포, 미생물, 오염물질을 제거하거나 분해하여야 하는데, 여기서 상기 세포, 미생물, 오염물질들을 분해하기 위해 단백질 분해 효소(protease)를 분비하게 된다.In addition, when the wound of the skin is damaged to the internal tissues along with damage to the skin or mucous membrane covering the main part of the body, the damaged skin or mucous membrane contains dying cells, microorganisms, contaminants, Cells, microorganisms and contaminants contained must be removed or degraded, whereby protease is secreted to degrade the cells, microorganisms and contaminants.
그러나 상기 분비되는 단백질 분해 효소가 과잉 분비되는 경우, 과잉 단백질 분해 효소는 세포의 성장 및 세포 부착에 필수적인 세포 간 콜라겐(Collagen) 매트릭스와 엘라스틴(Elastin)매트릭스를 분해 및 파괴시켜 세포의 성장을 억제하여 상처 치유를 지연시키게 된다.However, when the secreted protease is excessively secreted, the excess protease decomposes and destroys the intercellular collagen matrix and elastin matrix, which are essential for cell growth and cell adhesion, thereby inhibiting cell growth. This will delay wound healing.
그래서 상기 단백질 분해 효소(protease)를 억제하면 상기 세포 간 매트릭스(MMPs:matrix metalloproteins)에 부착하여 세포의 성장을 촉진시키게 된다.Therefore, inhibition of the protease promotes cell growth by attaching to the intercellular matrix (MMPs: matrix metalloproteins).
여기서 상기 세포 간 매트릭스(MMPs:matrix metalloproteins)는 세포와 세포 사이에 공간을 채워 주는 단백질, 콜라겐, 엘라스틴 히아루론산 등이 있다.Herein, the intercellular matrix (MMPs: matrix metalloproteins) include proteins, collagen, elastin hyaluronic acid, and the like, which fill a space between cells.
상기 세포 간 매트릭스(MMPs)는 서로 상이한 유형 있기 때문에, 그들은 중화 특정 폴리페놀의 다른 유형을 요구한다. 이는 서로 연관이 없어도 두 개의 특정 식물 추출물로 함으로써, 세포 간 기질의 분해를 중지하여 세포 성장에 대한 상승효과를 갖게 되므로, 상기 세포 간 매트릭스(MMPs)의 상이한 유형을 중화 폴리페놀 또는 다당류의 두 개 또는 세 가지 유형을 가지는 것도 가능하다.Since the intercellular matrices (MMPs) are of different types, they require different types of neutralizing specific polyphenols. These are two specific plant extracts that are not related to each other, thereby stopping the breakdown of the intercellular matrix and having a synergistic effect on cell growth. Thus, different types of intercellular matrix (MMPs) can be converted into two neutralizing polyphenols or polysaccharides. Alternatively, it is possible to have three types.
상기 식물성 추출물(허브 액기스)은 이집트 시대부터 가죽을 모두질 할 때 사용했던 탄닌산을 사용하게 되는데, 이것은 탄닌산이 단백질과 결합하는 능력이 있기 때문이다.The vegetable extract (herb extract) uses tannic acid, which has been used for all leather since Egyptian times, because tannic acid has the ability to bind proteins.
상기 탄닌산은 떫은 감에 있는 성분이며, 분자 구조상으로 볼 때, 폴리페놀(Polyphenol) 및 다당류(Polysaccharide)가 붙은 형태이며, 항산화 작용이 있는 짙은 색깔의 과일에 있는 프로시아니딘(procyanidine) 혹은 안소시아니딘(anthocyanidine)이라고 하기도 한다.The tannic acid is a component in the persimmon persimmon, and in terms of molecular structure, polyphenols and polysaccharides are attached, and procyanidine or ansocyanidin in a dark-colored fruit with antioxidant activity. Also called (anthocyanidine).
상기 단백질 분해효소와 결합하는 능력이 있는 허브 액기스는 알케미라 불가리스(Alchemilla vulgaris) 한 종류이며, 다른 액기스는 바이러스 혹은 다른 단백질과 결합한다. 그러므로 글리세린에 다른 허브액기스가 함유되어 있으면, 다른 종류의 상처에 효과가 있다.Herbal extracts that have the ability to bind to proteolytic enzymes are a type of Alchemilla vulgaris, and other extracts bind to viruses or other proteins. Therefore, if glycerin contains other herbal extracts, it is effective for other types of wounds.
여기서 상기 식물 추출물은 큰 분자를 침전하는 것으로 알려진 폴리페놀(Polyphenol) 및 다당류(Polysaccharide)가 단백질 분해 효소에 결합하여 단백질 분해 효소를 중화시킬 수 있다.Here, the plant extract may neutralize proteolytic enzymes by combining polyphenols and polysaccharides known to precipitate large molecules with proteolytic enzymes.
상기 폴리페놀(Polyphenol) 및 다당류(Polysaccharide)가 단백질에 대한 강한 친화성을 가지고, 그 일부 폴리페놀 또는 다당류는 박테리아 또는 바이러스성 단백질에 결합하여 감염, 미생물 기원의 독성 물질의 해방을 감소시켜 세포성장을 촉진하는데 도움이 된다.The polyphenols and polysaccharides have a strong affinity for proteins, and some polyphenols or polysaccharides bind to bacteria or viral proteins to reduce the release of toxic substances of infection, microbial origin, and cell growth. It helps to promote.
지난 십 수년간 피부 상처를 포함한 각가지 상처 치료를 위해 많은 제품들이 개발되었다. 이에 따라 상처 치료의 패러다임에도 많은 변화 들이 있었으며, 그 개념의 중심에 있는 것은 친수성 콜로이드(hydro-colloid), 친수성 폼(hydro-foam), 친수성 젤(hydro-gel)과 친수성 화이버(hydro-fiber)로 대표되는 습윤드레싱이라 할 수 있다. In the last decades, many products have been developed for the treatment of various wounds, including skin wounds. As a result, there have been many changes in the paradigm of wound healing, and at the heart of the concept are hydrophilic colloids, hydro-foams, hydro-gels and hydro-fibers. Wet dressing is represented by.
또한 최근 상처의 치유 기간을 단축시키기 위한 부가적인 치료재료로 성장인자(Epidermal growth factor and Fibroblast growth factor), hyaluronic acid dressing, Collagen dressing 및 Cultured epithelial allograft와 같은 다양한 생물학적 드레싱 제품들이 지속적으로 개발되어 습윤 드레싱 제품들과 함께 사용되고 있다.In addition, we recently developed various biological dressing products such as epidermal growth factor and fibroblast growth factor, hyaluronic acid dressing, collagen dressing and cultured epithelial allograft as additional therapeutic materials to shorten the wound healing period. It is being used with the products.
이와 같은 합성 제품과 생물학적 제품 외에도 상처의 치유를 위한 드레싱 제재로 자연에서 유래 된 다양한 물질들을 활용한 제품의 개발이 이루어지고 있다.In addition to such synthetic and biological products, the development of products utilizing various materials derived from nature as a dressing material for wound healing is being made.
이 일환으로 성모초(Alchemilla Vulgaris)는 허브의 일종으로 중세시대부터 위장관 장애의 치료와 상처의 치료에 이용되어 왔고, 미모사(Mimosa Tenuiflora)는 전통적으로 피부의 상처나 화상의 치료, 그리고 구강의 상처 등을 치료하는데 상기 두 허브 추출물에는 프로시아니딘(Procyanidins)이 풍부하다. As part of this, Alchemilla Vulgaris is a herb that has been used for the treatment of gastrointestinal disorders and wounds since the Middle Ages, and Mimosa (Timosa Tenuiflora) has traditionally been used to treat skin wounds, burns, and oral wounds. Both herbal extracts are rich in Procyanidins.
상기 프로시아니딘이 상처의 치유를 촉진시키는 기전에 대해서는 아직 명확하지 않지만 상처에서 프로테아제(protease)와 세포 간 매트릭스(MMPs)를 분해하는 다른 효소들(intercellular matrix degrading enzymes)의 활성을 억제함으로써 상처 치유를 돕는 세포의 부착과 성장에 도움이 되는 환경을 형성하여 치유를 촉진시키는 것으로 추정되고 있다.The mechanism by which procyanidins promote wound healing is not yet clear, but it helps to heal wounds by inhibiting the activity of protease and other cellular degrading enzymes (MMPs) in the wound. It is estimated to promote the healing by forming an environment conducive to cell adhesion and growth.
또한 상처 치유를 위해 콜라겐을 이용하게 되는데, 상기 콜라켄은 대부분 동물이나 사람에 있는 특히 피부, 근육과 힘줄과 같은 연결 조직에서 발견되는 섬유성 단백질로서. 상기 콜라겐은 혈액과 접촉할 때, 혈소판이 콜라겐에 응집하고 플라즈마와 함께 박리되는 응고인자를 유지하여 최종적으로 피브린과 혈전을 형성하여 지혈 작용을 하게 된다.Collagen is also used for wound healing, which is a fibrous protein found in most connective tissues such as skin, muscles and tendons, especially in animals and humans. When collagen comes into contact with blood, platelets aggregate to collagen and maintain coagulation factors that are released together with plasma to finally form fibrin and thrombus to act as a hemostatic action.
콜라겐을 상처 치료의 목적으로 사용할 때 최초의 제형은 분말이다. 상처 치료과정에서 콜라겐은 가장 먼저 빈 공간에 임시적으로 형성되는 단백질이므로 상처 치료를 촉진할 것이라는 기대에도 불구하고 분말 제형은 몇 가지 단점이 있기 때문에 사용이 제한되었다. When collagen is used for wound healing purposes, the first formulation is a powder. Collagen is the first protein to be temporarily formed in the empty space during the wound treatment process, and despite the expectation that it will promote wound healing, the powder formulation has been limited in use due to some disadvantages.
콜라겐 분말을 상처 부위에 뿌리면 상처 부위의 삼출물을 흡수하여 건조하게 되므로 통증을 유발하고 습기가 없기 때문에 상처가 정상적인 치료과정을 거치지 못하고 상흔이 크게 남게 된다.When collagen powder is sprayed on the wound site, the exudates from the wound area are absorbed and dried, causing pain and lack of moisture, leaving the wound unscathed and leaving a significant scar.
이러한 단점을 보완하기 위해서 스폰지 형태의 콜라겐 제품이 개발되었으나 이 제형도 다른 단점을 유발하였다. 스폰지 형태의 제품을 상처부위에 덮으면 상처와 밀착하지 못하고 빈 공간이 생기기 때문에 상처 치료가 상처 치료를 촉진하는 효과가 크지 않았다. Sponge-type collagen products have been developed to compensate for these drawbacks, but this formulation also caused other drawbacks. When the sponge-like product was covered on the wound area, the wound treatment did not have much effect to promote the wound treatment because it could not be in close contact with the wound and an empty space was created.
이러한 단점을 보완하기 위해서 새로운 제형의 스폰지를 파쇄하여 도로 콜라겐 분말을 만들어서 식염수와 혼합하여 페이스트 혹은 반죽으로 만들어서 상처 부위에 도포하는 제품이 미국 등록특허 제 4,891,359호 (지혈제 콜라겐 페이스트 조성물) 개발되었다. In order to make up for this drawback, a new formulation was developed by crushing a sponge of a new formulation to make road collagen powder, mixed with saline solution, and then making it into a paste or dough to apply to a wound site. US Patent No. 4,891,359 (Hemostatic Collagen Paste Composition) was developed.
이 제품은 콜라겐 분말에 식염수를 혼합 조성하여, 페이스트(paste) 또는 반죽으로 조성하여 상처표면에 밀접하게 적용하여 간편하게 지혈 및 지혈 후 상처 부위에서 쉽게 제거할 수 있도록 조성하였다. This product was prepared by mixing saline with collagen powder, paste or paste, and applying it closely to the wound surface to easily remove it from the wound after hemostasis and hemostasis.
그러나 상기 종래 기술은 콜라겐에 식염수만을 혼합하여 상처 표면에 밀접하게 접촉되게 하여 단지 지혈제로 사용하는 것에 불과할 뿐 상처 치유를 촉진하는 효과에는 미흡한 문제점이 있으며, 또한 수분은 쉽게 증발하기 때문에 공기 차단 효과가 적어서 통증 완화 효과가 낮고 쉽게 건조해 지는 문제점이 있다.However, the prior art is not only used as a hemostatic agent by mixing saline with collagen to be in close contact with the wound surface, but there is an insufficient problem of promoting wound healing, and moisture is easily evaporated. There is a problem that the pain relief effect is low and dries easily.
상기 문제점을 해결하고자 하는 본 발명의 과제는 상처 내부로부터 삼출물을 배출하여, 미생물 및 기타 오염물질을 제거하고, 단백질 분해 효소를 억제하여 그들의 활성을 중화함으로써 매트릭스의 분해를 억제시켜서 상처 부위의 세포 성장 및 치료를 촉진할 뿐만 아니라 콜라겐을 첨가하여 밀도를 높여서 공기와의 차단효과를 증대시켜서 통증 완화 효과를 증대 시키는데 있다.An object of the present invention to solve the above problems is to discharge the exudate from the inside of the wound, to remove microorganisms and other contaminants, to inhibit proteolytic enzymes to neutralize their activity by inhibiting the decomposition of the matrix cell growth of the wound site And not only to promote treatment, but also to increase the density by adding collagen to increase the blocking effect with the air to increase the pain relief effect.
상기 과제의 해결에 따른 본 발명의 수단은 식물성 추출물 2wt% ~ 5wt%를 함유하여 50wt% ~ 95wt%가 되는 액상의 글리세린에 분말 상의 콜라겐 5wt% ~ 50wt%를 혼합하는 것을 특징으로 한다. Means of the present invention according to the solution of the above problem is characterized by mixing 5wt% to 50wt% of powdered collagen in a liquid glycerin containing 2wt% to 5wt% of the vegetable extract to 50wt% to 95wt%.
상기 본 발명의 수단에서 상기 식물성 추출물은 비티스 비니페라(Vitis vinifera), 카멜리아시넨시스(Camellia sinensis), 바시니움 에스피.(Vaccinium sp.), 바시니움 미르티루스(Vaccinoum myrtillus), 알케미라 불가리스(Alchemilla vulgaris), 미모사 테누이플로라(Mimosa tenuiflora), 에키나세아 프르푸라(Echinacea purpura) 중 어느 하나의 엑기스 인 것을 특징으로 한다.In the means of the present invention, the vegetable extract is Vitis vinifera, Camellia sinensis, Basinium sp., Vaccinium sp., Vaccinoum myrtillus, Alchemilla vulgaris (Alchemilla vulgaris), Mimosa tenuiflora (Mimosa tenuiflora), Echinacea purpura (Echinacea purpura) is characterized in that the extract.
상기 과제 해결수단에 따른 본 발명의 효과는 허브액기스를 함유한 글리세린에 콜라겐을 혼합하여 피부 상처에 도포하여 줌으로써, 피부 상처에 도포된 글리세린은 높은 삼투압에 의해 피부 내부로부터 피부 상처에 삼출물을 배출시켜서 감염된 세균 및 기타 오염물질을 살균하고, 허브액기스는 세포간 매트릭스를 파괴하는 단백질 분해효소를 중화시켜서 매트릭스를 복구하여 세포의 성장을 촉진함으로써 상처 치료를 촉진하며, 상기 콜라겐은 단백질 분해효소를 더욱 빠르게 중화시킬 뿐만아니라, 글리세린과 함께 수분증발을 억제하여 보습 상태를 유지함으로써 통증 완화 효과와 상처의 덮개 역할을 해 주고 상처 치료효과를 촉진해 준다. The effect of the present invention according to the problem solution means by applying collagen to the skin wound by mixing the glycerin containing the herbal extract, the glycerin applied to the skin wound is discharged exudates from the inside of the skin wound by the high osmotic pressure to the skin wound Sterilizes infected bacteria and other contaminants, herbal extracts promote wound healing by neutralizing proteolytic enzymes that break down the intercellular matrix, repairing the matrix and promoting cell growth, and the collagen accelerates protease faster It not only neutralizes, but also maintains a moisturizing condition by inhibiting water evaporation along with glycerin, which acts as a pain relief and wound cover and promotes wound healing.
도 1은 본 발명 피부 상처 치료제를 욕창에 도포 전,후 치료결과 사진1 is a photograph of the result of the treatment before and after applying the present invention skin wound treatment to bedsores
도 2는 본 발명 피부 상처 치료제를 욕창에 도포 전,후 치료결과 사진Figure 2 before and after the application of the present invention skin wound treatment to the bedsores photograph
도 3은 본 발명 피부 상처 치료제를 욕창에 도포 전,후 치료결과 사진Figure 3 before and after applying the present invention skin wound treatment to the bedsores treatment result photograph
도 4는 본 발명 피부 상처 치료제를 화상에 도포 전,후 치료결과 사진Figure 4 before and after the application of the present invention skin wound treatment on the burn photo
본 발명은 액상의 글리세린(Glycerol)에 분말상의 콜라겐(collagen)을 혼합하여 제조하게 된다. 상기 글리세린(Glycerol)은 식물성 추출물 또는 허브 엑기스 중 어느 하나를 함유하게 된다. 바람직하게는 허브 엑기스를 함유한다.The present invention is prepared by mixing powdered collagen (collagen) to a liquid glycerin (Glycerol). The glycerin (Glycerol) will contain any one of vegetable extracts or herbal extracts. Preferably it contains a herb extract.
이하, 첨부된 도면을 토대로 하여 실시에를 설명하기로 한다.Hereinafter, embodiments will be described based on the accompanying drawings.
상기 글리세린(Glycerol)은 높은 보습효과로 상처를 치유할 수 있으나, 상기 보습효과로 통증을 완하하는 효과는 극히 일부에 지나지 않는다. 높은 농도의 글리세린은 체 내의 세포를 수축하여 외부로 이동하는 삼출물을 조직 밖으로 끌어내고 상기 끌어낸 삼출물은 후술할 허브 엑기스와 결합하여 다시 체 내로 들어가는 것을 막아준다.The glycerin (Glycerol) can heal the wound with a high moisturizing effect, but only a very small effect of relieving pain by the moisturizing effect. The high concentration of glycerin constricts the cells in the sieve and draws out exudate that moves out of the tissue, and the exudate exudes in combination with the herb extract, which will be described later, to prevent it from entering the sieve.
즉 고장액(hypertonic solution)의 경우 삼투압이 높아서 피부 속의 삼출물이 글리세린 쪽으로 이동하여 나오고, 고장액 속의 허브엑기스에 종류에 따라 다른 물질을 잡아서 조직 속으로 다시 들어가지 못하게 된다. 그러므로 상기 글리세린은 허브엑기스와 결합하여 더욱 점도가 높아진 상태에서 상처 위에 필름막을 도포하게 된다.That is, in the case of hypertonic solution, the osmotic pressure is high so that the exudate in the skin moves toward the glycerin, and the herbal extracts in the hypertonic solution do not re-enter the tissue by catching different substances. Therefore, the glycerin is combined with the herbal extract to apply a film on the wound in a state where the viscosity is higher.
상기 글리세린은 높은 삼투압을 가지며, 폴리머의 형태로 결합력을 갖고 있기 때문에 조직 속으로 침투하지 않고 상처 밖에서 존재한다. 따라서 조직 밖으로 삼출물이 나오면 상처 내에 있는 바이러스 및 오염물질도 함께 따라 나오기 때문에 상처를 깨끗하게 해 주고, 상처의 치료를 촉진하게 된다. The glycerin has a high osmotic pressure and a binding force in the form of a polymer, so it exists outside the wound without penetrating into the tissue. Therefore, exudates come out of the tissues along with viruses and contaminants in the wound to clean the wound and facilitate the healing of the wound.
상기 허브 엑기스는 식물에 존재하는 탄닌(tannin)성분으로, 상기 글리세린의 히드록실기와 탄산기와 단백질이 결합하여 침전을 이루고, 각각의 탄닌은 다른 종류의 작용을 한다. 따라서 허브 엑기스의 종류에 따라 다른 효과를 나타내며, 치료할 수 있는 질병의 종류도 다양하다.The herbal extract is a tannin component present in the plant, and the hydroxyl group and the carbonic acid group of the glycerin are combined to form a precipitate, and each tannin has a different kind of action. Therefore, different types of herbal extracts have different effects, and there are various types of diseases that can be treated.
상기 콜라겐은 삼중 나선형 구조로서 특히 하이드로프롤린의 함량이 많은 단백질 물질이고, 물, 묽은 산, 묽은 알칼리에 녹지 않지만, 끊이면 용해되어 젤라틴이 된다. 상처에 도포 시 임시 피부의 역할을 하여 상처 치료를 촉진하게 된다.The collagen is a triple helical structure, especially a protein substance with a high hydroproline content, and is insoluble in water, dilute acid and dilute alkali, but dissolves and becomes gelatin. When applied to the wound, it acts as a temporary skin to promote wound healing.
실시예 Example
액상의 글리세린 50wt% ~ 95wt%에, 40 내지 60 메쉬 입자 크기의 분말 상의 콜라겐 5wt% ~ 50wt%를 혼합한 후, 내부의 공기 압력을 낮춘 후 저어서 제조하게 된다.50wt% to 95wt% of liquid glycerin is mixed with 5wt% to 50wt% of collagen in powder form of 40 to 60 mesh particles, and then prepared by lowering the internal air pressure.
상기 액상의 글리세린은 식물성 추출물을 포함하게 된다.The liquid glycerin will contain a vegetable extract.
상기 식물성추출물은 2wt% ~ 5wt%를 함유하게 된다.The vegetable extract will contain 2wt% ~ 5wt%.
상기 식물성 추출물은 비티스 비니페라(Vitis vinifera), 카멜리아시넨시스(Camellia sinensis), 바시니움 에스피.(Vaccinium sp.), 바시니움 미르티루스(Vaccinoum myrtillus), 알케미라 불가리스(Alchemilla vulgaris), 미모사 테누이플로라(Mimosa tenuiflora), 에키나세아 프르푸라(Echinacea purpura) 중 어느 하나의 엑기스를 사용하게 된다.The plant extracts are Vitis vinifera, Camellia sinensis, Vaccinium sp., Vaccinoum myrtillus, Alchemilla vulgaris ), Extracts of any one of Mimosa tenuiflora and Echinacea purpura will be used.
여기서 본 발명은 액상의 글리세린 90wt%에 상기 콜라켄은 10wt%를 함유하는 것이 바람직하다.Herein, the present invention preferably contains 90 wt% of the liquid glycerin and 10 wt% of the collagen.
그러므로 활성 고장성 성분은 글리세린에 의해 상처 내부에서 외부로 삼출물을 배출하면서 상처의 미생물 및 기타 오염물질을 밖으로 분리 배출하게 되어 상처의 내부를 깨끗하게 해 주어 상처의 치료를 촉진하게 된다.Therefore, the active hypertonic component releases the exudates from the inside of the wound to the outside by glycerin, thereby separating and discharging the microorganisms and other contaminants of the wound outwards, thereby facilitating the healing of the wound.
상기 외부로 분리 배출되는 미생물 및 오염물질의 삼출물은 프로시아니딘이 풍부한 허브 엑기스로 흡착하여 상기 삼출물이 다시 내부로 유입되는 것을 방지하고, 세포 간에 매트릭스를 파괴하는 단백질 분해 효소를 억제시켜 그들의 활성을 중화하여 세포 간에 매트릭스를 증식함으로써 치료를 촉진하게 된다.The exudates of microorganisms and contaminants that are separated and discharged to the outside are adsorbed with procyanidin-rich herbal extracts to prevent the exudates from entering the inside again and neutralize their activities by inhibiting proteolytic enzymes that destroy the matrix between cells. Proliferation of the matrix between cells promotes treatment.
상기 콜라겐은 세포외 기질을 구성하는 구조 단백질로서, 다수의 당 단백 분자로 구성된 백색의 투명한 무분지 원섬유이며. 콜라겐 단백질의 모노머는 프로콜라겐으로 프로콜라겐 분자는 가늘고 긴 세 가닥의 나선형 사슬로 이루어져 있으며, 전자현미경으로 직경 1.5nm, 길이 약 300nm, 상대분자질량이 2.85×105로 안정적인 3중 나선 공간 구조를 갖는 특수한 아미노산으로 구성되어 있다. The collagen is a structural protein constituting the extracellular matrix, a white transparent unbranched fibrils composed of a plurality of sugar protein molecules. The monomer of collagen protein is procollagen, and the procollagen molecule is composed of three long and thin spiral chains.The electron microscope has a stable triple helix space structure of 1.5nm in diameter, 300nm in length and 2.85 × 105 in relative molecular mass. It is composed of special amino acids.
상기 콜라겐은 세포와 세포 사이를 연결하여 살과 결합조직을 형성하는 단백질로서, 세포간 메트릭스로서 존재하고, 신체를 구성하는 단백질 중 25%에서 35%를 차지하고 있고 섬유 형태의 단백질로 힘줄, 인대, 피부와 같은 섬유조직에 존재한다.The collagen is a protein that connects cells to cells to form flesh and connective tissue, and exists as an intercellular matrix, and accounts for 25% to 35% of the proteins constituting the body and is a fibrous form of tendons, ligaments, It is present in fibrous tissues such as skin.
상기 콜라겐은 동물의 피부나 연골에 많이 들어있는 특수 단백질이다. 물에는 녹지 않고 물에 가열하여 추출되고 가열 추출되면 입체구조가 붕괴되어 젤라틴이라는 변성 단백질, 즉 가열시 액체가 되고, 냉각시 고체가 되는 성질을 가지게 된다.The collagen is a special protein contained in animal skin or cartilage. It is insoluble in water, extracted by heating in water, and extracted by heating. The steric structure is collapsed to have a denatured protein called gelatin, that is, a liquid upon heating and a solid upon cooling.
그러므로 상기 콜라겐은 피부의 상처에 도포시 피부의 세포와 세포를 결합하여 피부의 두께를 증진함과 아울러, 피부의 수분 증발을 억제하여 지혈작용, 저항원성, 붕해성 및 생체적합성을 가지며, 임상 지혈 및 세포 생장 촉진하여 상처 치료를 촉진하게 된다.Therefore, when the collagen is applied to the wound of the skin, it combines the cells of the skin and the cells to promote the thickness of the skin, and also inhibits the evaporation of the moisture of the skin to have a hemostatic action, resistance, disintegration and biocompatibility, clinical hemostasis And promote cell growth to promote wound healing.
실시예1Example 1 실시예2Example 2 실시예3Example 3
글리세린(wt%)+허브엑기스(wt%)Glycerin (wt%) + Herb Extract (wt%) 5050 9090 9595
콜라겐(wt%)Collagen (wt%) 5050 1010 55
실시예 1 내지 3으로 조성한 젤 형태의 본 발명제를 도 1의 사진에서 보는 바와 같이, 욕창 환자의 상처에 1g 두께로 도포하여 치료하였다.As shown in the photograph of FIG. 1, the present invention in the form of a gel prepared in Examples 1 to 3 was treated by applying a thickness of 1 g to the wound of a bed sore patient.
그 결과 일반 치료제로 치료를 시작한 욕창 부위는 1일 1회 10일 후에도 상처부위가 오히려 악화된 상태를 보였으나, 본 발명제로 1주에 3회 7주를 치료한 결과 상처부위에 상흔은 남아 있으나 말끔하게 치유된 결과를 보였다.As a result, the wound area that started treatment with the general treatment showed a deteriorated state even after 10 days once a day, but after 7 weeks of treatment three times a week with the present invention, the wound remains. Neatly healed.
또한 본 발명제를 도 2의 사진에서 보는 바와 같이, 욕창 환자의 상처에 1g 두께로 도포하여 치료하였다.In addition, the present invention was treated by applying a 1g thickness to the wound of the bed sore patient, as shown in the photo of FIG.
그 결과 일반 치료제로 치료를 시작한 욕창 부위는 1일 1회 11주 후에도 상처부위가 오히려 악화된 상태를 보였으나, 본 발명제로 4주에 4회 치료한 결과 상처부위에 상흔은 거의 남아 있지 않고 비교적 말끔하게 치유된 결과를 보였다.As a result, the wound site that started treatment with the general treatment showed a worse condition after 11 weeks once a day, but after 4 treatments with the present invention 4 times a week, scars remained relatively little at the wound site. Neatly healed.
또한 본 발명제를 도 3의 사진에서 보는 바와 같이, 욕창 환자의 상처에 1g 두께로 도포하여 치료하였다.In addition, the present invention was treated by applying a thickness of 1g to the wound of the bed sore patient, as shown in the photo of FIG.
그 결과 일반 치료제로 치료를 시작한 욕창 부위는 1일 1회 1주 후 상처부위가 많이 치료된 상태를 보였으나, 본 발명제로 1주 2회, 5주에 10회 치료한 결과 상처부위에는 말끔하게 치유되지 않았지만 거의 치유되고 있는 결과를 보였다.As a result, the decubitus area that started treatment with a general treatment showed a lot of wounds after 1 week once a week, but as a result of treatment twice a week and 10 times every 5 weeks with the present invention, the wound site was neat. It did not heal, but it was almost healing.
이어서 또한 본 발명제를 도 4의 사진에서 보는 바와 같이, 화상 환자의 상처에 1g 두께로 도포하여 치료하였다.Next, the present invention was also treated by applying a thickness of 1 g to the wound of the burn patient, as shown in the photograph of FIG. 4.
그 결과 일반 치료제로 치료를 시작한 화상 부위는 1일 1회 12주 후 상처부위가 많이 치료된 상태를 보였으나, 본 발명제로 1주 2회, 5주에 10회 치료한 결과 일반치료제를 치료한 화상 상처부위는 거의 말끔하게 치유되었지만 본 발명제로 치료를 시작한 화상 상처의 경우에 상기 일반치료제로 치료한 시작한 기간과 횟수를 비교하여 볼 때 상당히 빠른시간에 치유되고 있음을 알 수 있었다. As a result, the burned area that started treatment with the general treatment showed a lot of wounds after 12 weeks once a day, but the treatment with the general treatment was performed twice a week and 10 times in 5 weeks with the present invention. Although the burn wound was almost neatly healed, it was found that in the case of the burn wound that started treatment with the present invention, the wound wound was healed in a relatively fast time compared to the number of times of the start of treatment with the general treatment.
따라서 상기 도 1 내지 도 4에 나타난 바와 같이 상기 본 발명제로 욕창 및 화상부위의 상처를 치료한 것이 일반 치료제로 치료하였을 때 보다 상당히 빠른시간 내에 치유는 물론 상처부위에 상흔이 거의 남지 않고 깨끗하게 치료되는 것을 알 수 있었다.Therefore, as shown in Figs. 1 to 4, the wounds of the bedsores and burns with the present invention are cured in a considerably faster time than the general treatment, and the wounds are cleanly cleared with almost no scars on the wounds. I could see that.
종래 기술은 콜라겐에 식염수만을 혼합하여 상처 표면에 밀접하게 접촉되게 하여 단지 지혈제로 사용하는 것에 불과할 뿐 상처 치유를 촉진하는 효과에는 미흡한 문제점이 있으며, 또한 수분은 쉽게 증발하기 때문에 공기 차단 효과가 적어서 통증 완화 효과가 낮고 쉽게 건조해 지는 문제점이 있었던 것을 본 발명에서는 이러한 종래의 문제점을 해소시켜 준 상태에서 사용할 수 있도록 하는 것이다.The prior art is not only used as a hemostatic agent by adhering saline to collagen but in close contact with the wound surface, and there is an insufficient problem of promoting wound healing. In the present invention, there was a problem that the relaxation effect was low and easily dried, so that the conventional problem could be solved.

Claims (2)

  1. 식물성추출물 2wt% ~ 5wt%를 함유하여 50wt% ~ 95wt%가 되는 액상의 글리세린에 분말상의 콜라겐 5wt% ~ 50wt%를 상온에서 혼합하여 조성하는 것을 특징으로 하는 피부 상처 치료조성물.A composition for treating skin wounds comprising mixing 2wt% to 5wt% of vegetable extracts and mixing 5wt% to 50wt% of powdered collagen at room temperature in a liquid glycerin which is 50wt% to 95wt%.
  2. 제 1 항에 있어서, The method of claim 1,
    상기 식물성추출물은 비티스 비니페라(Vitis vinifera), 카멜리아시넨시스(Camellia sinensis), 바시니움 에스피.(Vaccinium sp.), 바시니움 미르티루스(Vaccinoum myrtillus), 알케미라 불가리스(Alchemilla vulgaris), 미모사 테누이플로라(Mimosa tenuiflora), 에키나세아 프르푸라(Echinacea purpura) 중 어느 하나의 엑기스 인 것을 특징으로 하는 피부 상처 치료조성물.The vegetable extract is Vitis vinifera, Camellia sinensis, Basinium sp., Vaccinium myrtillus, Alchemyra vulgaris ), Mimosa tenuiflora, Echinacea purpura extract of any one of the skin wound composition.
PCT/KR2016/009107 2015-08-19 2016-08-18 Composition for treating skin wounds WO2017030388A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201680019591.4A CN107427561A (en) 2015-08-19 2016-08-18 Skin wound therapeutic combination

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0116661 2015-08-19
KR1020150116661A KR101649450B1 (en) 2015-08-19 2015-08-19 Skin wound healing composition

Publications (2)

Publication Number Publication Date
WO2017030388A1 true WO2017030388A1 (en) 2017-02-23
WO2017030388A9 WO2017030388A9 (en) 2018-03-01

Family

ID=56874658

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/009107 WO2017030388A1 (en) 2015-08-19 2016-08-18 Composition for treating skin wounds

Country Status (3)

Country Link
KR (1) KR101649450B1 (en)
CN (1) CN107427561A (en)
WO (1) WO2017030388A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108125903A (en) * 2018-01-19 2018-06-08 深圳光彩生命工程技术有限公司 A kind of novel stem cells composite factor anti-aging cosmetics

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101904196B1 (en) 2017-04-18 2018-10-04 이상철 Skin wound healing composition
CN109364086B (en) * 2018-11-28 2020-12-15 福建师范大学 Method for improving aminoglycoside antibiotic sterilization efficiency by hypertonic glycerol pretreatment
KR102292114B1 (en) * 2020-11-13 2021-08-20 주식회사 피에프네이처 Composition for Improving Skin Conditions Having Moisturizing, Anti-Inflammatory Caused by Fine Dust and Pore Shrinkage Property Comprising Plant Complex Extracts as Active Ingredient

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891359A (en) * 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
KR20090060449A (en) * 2006-10-13 2009-06-12 우루루 인코퍼레이티드 Hydrogel wound dressing and biomaterials formed in situ and their uses
KR20100030031A (en) * 2008-09-09 2010-03-18 한스바이오메드 주식회사 Human skin regenerative powder from alloskin source
KR20110102811A (en) * 2010-03-11 2011-09-19 이상철 Medical treatment of composite
KR20120015783A (en) * 2010-08-13 2012-02-22 주식회사 셀랩 A hydrogel composition for transdermal administration of drug

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1402749B1 (en) * 2010-10-28 2013-09-18 Indena Spa COMPOSITIONS FOR THE TREATMENT OF PERIPHERAL ULCERS OF VARIOUS ORIGIN
CN104394875B (en) * 2012-03-14 2018-12-04 Izun制药公司 For treating the novel method and composition of disease
ITTO20130091A1 (en) * 2013-02-04 2014-08-05 Silvachimica S R L COMPOSITION FOR THE PRODUCTION OF AN ELASTIC EXPANDED MATERIAL TANNINED, AND ITS PROCEDURE.
CN103520708A (en) * 2013-10-22 2014-01-22 易金阳 Composition capable of promoting wound healing and reducing scarring
CN103989828A (en) * 2014-05-21 2014-08-20 海南生态美生物科技有限公司 Composition for promoting wound healing and preparation method thereof
KR101768870B1 (en) * 2015-04-13 2017-08-17 주식회사 래디안 Cosmetic composition and pharmaceutical composition with sinapic acid or the extract of cynanchum atratum for wound healing

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891359A (en) * 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
KR20090060449A (en) * 2006-10-13 2009-06-12 우루루 인코퍼레이티드 Hydrogel wound dressing and biomaterials formed in situ and their uses
KR20100030031A (en) * 2008-09-09 2010-03-18 한스바이오메드 주식회사 Human skin regenerative powder from alloskin source
KR20110102811A (en) * 2010-03-11 2011-09-19 이상철 Medical treatment of composite
KR20120015783A (en) * 2010-08-13 2012-02-22 주식회사 셀랩 A hydrogel composition for transdermal administration of drug

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108125903A (en) * 2018-01-19 2018-06-08 深圳光彩生命工程技术有限公司 A kind of novel stem cells composite factor anti-aging cosmetics

Also Published As

Publication number Publication date
WO2017030388A9 (en) 2018-03-01
KR101649450B1 (en) 2016-08-18
CN107427561A (en) 2017-12-01

Similar Documents

Publication Publication Date Title
Boateng et al. Advanced therapeutic dressings for effective wound healing—a review
CA2630147C (en) Compositions for disrupting and inhibiting reconstitution of wound biofilm
CN102670929B (en) Composite for injury healing and preparing method thereof
WO2017030388A1 (en) Composition for treating skin wounds
US8426384B2 (en) Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate
Santhanam et al. Bovine based collagen dressings in wound care management
CN1194777C (en) Artificial skin and its prepn and use
US20080102106A1 (en) Wound Healing Composition Comprising Substances From Diptera Larvae
KR101904196B1 (en) Skin wound healing composition
RU2108114C1 (en) Biological composition to treat wounds
CN113648350A (en) Preparation method of toad feeding hydrogel dressing
US20140030365A1 (en) Compositions for the debridement, granulation and reepithelialization of wounds in man
Khattabi et al. Complete Healing and Short-term Treatment by Argania Honey Dressing in a Venous Leg Ulcer: A Case Report
Waqiah et al. Potential Of Moringa Leaf Extract (Moringa Oleifera Lam) As Wound Medicine In Livestock
Pillay et al. Experimental Evaluation of Repair Process of Burn-Wounds Treated with 15 UMF Manuka Honey Yam Mun Fei,'AG Pillay and" Jamaludin Zainol
KR100289906B1 (en) Dermatological composition
CN114712397A (en) Medicine for treating burn, scald and burn prepared from animal fat cells
KR20150030585A (en) A composition for treating wound containing horse oil
KR20220144070A (en) Burn treatment composition containing egg shell powder as an active ingredient
Stashak et al. Topical wound treatments
KR20020087210A (en) Composition for Healing Injury
Bhattacharjee et al. A Technical Overview: Polymers for Wounds and Burns Dressing as Hydrogel Drug Delivery System
van Hengel et al. Chapter Wound and cats management: 2 a new protocol for dogs
FI20170117A1 (en) Active ingredients in a cream for treating inflamed skin
Grotte Honey as a Dressing for Wounds, Burns, and Ulcers

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16837330

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16837330

Country of ref document: EP

Kind code of ref document: A1